...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol
【24h】

Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol

机译:中央组织胺能传递对氟哌啶醇的抗癫痫药和抗精神病药作用的贡献

获取原文
获取原文并翻译 | 示例

摘要

The antipsychotic properties of haloperidol are primarily attributed to its ability to block dopamine D-2 receptors. Histaminergic transmission modulates some of the behavioral effects of haloperidol. Hence, the present study investigated the contribution of central histaminergic transmission in the cataleptic and neuroleptic effect of haloperidol respectively, using bar test and conditioned avoidance response (CAR) in a two-way shuttle box. The studies revealed that haloperidol (0.50 or 1 mg/kg, i.p.) exhibited cataleptic behavior and inhibited conditioned avoidance response (CAR) in the doses 0.25 or 0.50 mg in rats. The rats, pretreated centrally (i.c.v.) with histamine precursor, L-histidine (1, 2.5 mu g) or histamine neuronal inducer (H-3 receptor antagonist), thioperamide (20,50 mu g/rat), showed an enhanced cataleptic effect with sub-maximal dose of haloperidol (0.5 mg/kg, i.p.). Similarly, the neuroleptic effect of haloperidol (0.25 mg/kg, i.p.) in CAR was also potentiated in the rats pretreated with L-histidine (2.5 mu g) or thioperamide (50 mu g/rat). Further, the cataleptic effect of haloperidol (1 mg/kg, i.p.) was attenuated in rats pretreated with the H-1 receptor antagonist, chlorpheniramine (60, 80 mu g/rat, i.c.v.) or H-2 receptor antagonist, ranitidine (60 mu g/rat, i.c.v.). However, the neuroleptic effect of haloperidol (0.5 mg/kg, i.p.) was completely reversed by pretreatment with ranitidine (60 mu g/rat, i.c.v.), and partially attenuated by chlorpheniramine (80 mu g/rat, i.c.v.). These findings suggest the possible involvement of histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol probably via H-1 or H-2 receptor stimulation. (C) 2015 Elsevier Inc. All rights reserved.
机译:氟哌啶醇的抗精神病特性主要归因于其阻断多巴胺D-2受体的能力。组胺能传递调节氟哌啶醇的某些行为影响。因此,本研究在双向穿梭箱中使用巴氏试验和条件回避反应(CAR)分别研究了中枢组胺能传递对氟哌啶醇的抗癫痫药和抗精神病药的作用。研究表明,氟哌啶醇(0.50或1 mg / kg,腹腔注射)在大鼠中表现出抗感性行为,并抑制了0.25或0.50 mg的条件回避反应(CAR)。用组胺前体,L-组氨酸(1,2.5μg)或组胺神经元诱导剂(H-3受体拮抗剂),硫代过酰胺(20,50μg/大鼠)进行中枢(icv)预处理的大鼠表现出增强的抗感作用含次最大剂量的氟哌啶醇(0.5 mg / kg,腹膜内)。同样,氟哌啶醇(0.25 mg / kg,腹腔注射)在CAR中的抗精神病作用在用L-组氨酸(2.5μg)或硫代过酰胺(50μg /大鼠)预处理的大鼠中也得到了增强。此外,氟哌啶醇(1 mg / kg,腹腔注射)在用H-1受体拮抗剂,扑尔敏(60,80μg /大鼠,icv)或H-2受体拮抗剂,雷尼替丁(60)预处理的大鼠中的致敏作用减弱。克/鼠,icv)。但是,氟哌啶醇(0.5 mg / kg,腹腔注射)的抗精神病作用通过雷尼替丁(60μg/大鼠,腹腔注射)的预处理被完全逆转,并被氯苯那敏(80μg/大鼠,腹腔注射)减弱。这些发现表明,组胺能传递可能通过H-1或H-2受体刺激参与氟哌啶醇的镇痛和神经镇痛作用。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号